Home » Market News » DirectorsTalk Highlights » Presentation from Skinbiotherapeutics at Shares and AJ Bell Investor Evening
SkinBiotherapeutics Plc

Presentation from Skinbiotherapeutics at Shares and AJ Bell Investor Evening

CEO Cath O’Neill discusses Skinbiotherapeutics at the recent Shares and AJ Bell Investor Evening

 

Skinbiotherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.